Skip to main content

Neonatology

0
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
The Impact of Non-Routine Events on Neonatal SafetyN/A1 trial
Active Trials
NCT02756195Completed395Est. Jan 2022
Utah Medical
Utah MedicalIreland - Dublin
1 program
The Impact of Non-Routine Events on Neonatal SafetyN/A

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesThe Impact of Non-Routine Events on Neonatal Safety

Clinical Trials (1)

Total enrollment: 395 patients across 1 trials

NCT02756195Human BioSciencesThe Impact of Non-Routine Events on Neonatal Safety

The Impact of Non-Routine Events on Neonatal Safety

Start: Nov 2016Est. completion: Jan 2022395 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.